Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker
Head and neck squamous cell carcinoma (HNSCC) is a type of tumour with a relatively poor prognosis.In recent years, immune checkpoint inhibitors, such as CTLA-4 and PD-1/PDL-1 inhibitors, have improved the treatment status of advanced tumours.However, the emergence of drug resistance has brought difficulties to clinical treatment, and Plastic Car n